Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib R...

by Yuling Zhou, MS, Liang Zeng, MS, Nong Yang, MS, Yongchang Zhang, MD
Published 2020-06-01

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study

by Zhe Huang, Zhe Huang, Chunhua Zhou, Yi Xiong, Feng Yang, Feng Yang, Fanxu Zeng, Wenjuan Jiang, Yongchang Zhang, Haiyan Yang, Li Liu, Liang Zeng, Nong Yang, Nong Yang, Zhan Wang
Published 2022-11-01

Real‐world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non‐driver gene mutation advanced non‐small cell lung cancer

by Zhongtai Wang, Hui Zhang, Chunhua Zhou, Xiaoyan Long, Rui Guan, Nong Yang, Yongchang Zhang
Published 2019-04-01

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer

by Dehua Liao, Lun Yu, Dangang Shangguan, Yongchang Zhang, Bowen Xiao, Ni Liu, Nong Yang
Published 2022-06-01

Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non–small-cell lung cancer

by Li Liu, Shuo Zhang, Hai-Yan Yang, Chun-Hua Zhou, Yi Xiong, Nong Yang, Ye Tian
Published 2024-01-01

Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments

by Shanshan Chen, Jingyi Tang, Fen Liu, Wei Li, Ting Yan, Dangang Shangguan, Nong Yang, Dehua Liao
Published 2023-03-01

Re–Os geochronology of Cu and W–Mo deposits in the Balkhash metallogenic belt, Kazakhstan and its geological significance

by Xuanhua Chen, Wenjun Qu, Shuqin Han, Seitmuratova Eleonora, Nong Yang, Zhengle Chen, Fagang Zeng, Andao Du, Zhihong Wang
Published 2010-10-01

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospectiv...

by Li Liu, Farhin Shaheed Kalyani, Haiyan Yang, Chunhua Zhou, Yi Xiong, Songlin Zhu, Nong Yang, Jingjing Qu, Jingjing Qu
Published 2021-06-01

A Microfluidic Micropipette Aspiration Device to Study Single-Cell Mechanics Inspired by the Principle of Wheatstone Bridge

by Yong-Jiang Li, Yu-Nong Yang, Hai-Jun Zhang, Chun-Dong Xue, De-Pei Zeng, Tun Cao, Kai-Rong Qin
Published 2019-02-01

Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse...

by Dehua Liao, Dehua Liao, Zhigang Liu, Yongchang Zhang, Ni Liu, Dunwu Yao, Lizhi Cao, Yun Chen, Yilan Fu, Nong Yang, Daxiong Xiang
Published 2020-05-01

Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer

by Lianxi Song, Liang Zeng, Huan Yan, Qinqin Xu, Qing Xia, Jian Lei, Xiaoyan Chen, Xiaoping Hu, Zhan Wang, Hong Liu, Nong Yang, Yongchang Zhang
Published 2022-11-01

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study

by Yongchang Zhang, Lianxi Song, Liang Zeng, Yi Xiong, Li Liu, Chunhua Zhou, Haiyan Yang, Zhan Wang, Qing Xia, Wenjuan Jiang, Qinqin Xu, Nong Yang
Published 2022-09-01

Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancer

by Zhe Huang, Fang Wu, Qinqin Xu, Lianxi Song, Xiangyu Zhang, Zhan Wang, Li Deng, Yongchang Zhang, Liang Zeng, Nong Yang, Xiangxiang Pan, Peifang Wei
Published 2023-06-01

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers

by Kun-Yan Li, PhD, Yu Qiu, MS, Yun Jiang, BS, Chen-Hui Luo, MS, Xiao-Ping Lin, BS, Jing Wang, BS, Nong Yang, MS
Published 2014-12-01

Effect of cardiopulmonary bypass reoxygenation on myocardial dysfunction following pediatric tetralogy of Fallot repair

by Ji-nong Yang, Xiao-ming Zhang, Lu-yao Ma, Zhan-jie Lu, Si-qiang Zheng, Al-Wajih Hamzah, Yong-feng Shao, Hong Liu, Gao-li Liu
Published 2021-04-01

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study

by Chun-Hua Zhou, Feng Yang, Wen-Juan Jiang, Yong-Chang Zhang, Hai-Yan Yang, Liang Zeng, Li Liu, Yi Xiong, Fan-Xu Zeng, Zhan Wang, Nong Yang
Published 2021-11-01

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer

by Rui Zhou, Rui Zhou, Fan Tong, Fan Tong, Yongchang Zhang, Ruigang Zhang, Ruigang Zhang, Yawen Bin, Yawen Bin, Sheng Zhang, Sheng Zhang, Nong Yang, Xiaorong Dong, Xiaorong Dong
Published 2023-11-01

Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advan...

by Yongchang Zhang, Liang Zeng, Xiangyu Zhang, Yizhi Li, Lingli Liu, Qinqin Xu, Haiyan Yang, Wenjuan Jiang, Analyn Lizaso, Luting Qiu, Ting Hou, Jun Liu, Ling Peng, Nong Yang
Published 2021-10-01

Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma

by Yonggang Wang, Chang Wang, Yanqiao Zhang, Jiqing Hao, Nong Yang, Jvfeng Wang, Min Peng, Tianshu Liu, Guifang Zhang, Xianbao Zhan, Shan Zeng, Yifan Zhang, Yong Gao, Yang Yao
Published 2022-10-01

Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study

by Yongchang Zhang, Xiangyu Zhang, Ruiguang Zhang, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Chunwei Xu, Jun Liu, Wenxian Wang, Sai-Hong Ignatius Ou, Jiexia Zhang, Zhengbo Song, Nong Yang
Published 2021-09-01